Trial NCT01897714

View at ClinicalTrials.gov 
Org. Study IDs: O-12-M1

Last trial update was posted on 2020-10-23

MeSH Interventions

Dexamethasone

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Relapsed and/or Relapsed-refractory Multiple Myeloma

Stopping Reasons

The study was terminated at median 46-48 months long term follow-up and mature overall survival follow-up data.

Limitations And Caveats

Study is terminated and long-term follow-up ended due to Sponsor decision.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID